Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Occult Breast Carcinoma”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableLooking for participantsNCT05963464
What this trial is testing

RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

Who this might be right for
Breast CancerOccult Breast Carcinoma
European Institute of Oncology 300
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableActive Not RecruitingNCT05942092
What this trial is testing

ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion: Comparison Between Techniques.

Who this might be right for
Breast Cancer
Istituti Clinici Scientifici Maugeri SpA 1,400
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT06540872
What this trial is testing

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Universität Münster 30
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT02869230
What this trial is testing

ROLL vs WGLL for Non-palpable Breast Lesions

Who this might be right for
Breast Cancer
Instituto Nacional de Cancerologia, Columbia 129
Not applicableStudy completedNCT03660137
What this trial is testing

Magnetic Occult Lesion Localization and Imaging (MOLLI)

Who this might be right for
Breast Neoplasms
Sunnybrook Health Sciences Centre 20
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Not applicableStudy completedNCT03313908
What this trial is testing

Radioguided Occult Lesion Localisation by Indocyanine Green

Who this might be right for
Breast Cancer Female
University Hospital, Montpellier 10
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00824538
What this trial is testing

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Who this might be right for
Breast Cancer
University of California, San Francisco 13
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Not applicableStudy completedNCT02101320
What this trial is testing

Hand-held Gamma Camera in the SNOLL Procedure

Who this might be right for
Breast Cancer
Assistance Publique - Hôpitaux de Paris 47
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00429247
What this trial is testing

Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients

Who this might be right for
Breast Cancer
University Hospital of Crete 75
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Load More Results